Public health researchers believe the eye may be a key entry point for coronavirus to infect the body, in a world-first study that reveals the current strain is up to 100 times more infectious than SARS.
Read more
Scientists modify commercial contact lens to correct colour blindness
Researchers have modified an off-the-shelf contact lens to correct a form of red–green colour blindness known as deuteranomaly, the most common type of colour vision deficiency. Read more
Study findings suggest coronavirus replicates in the eye
A new study into Italy’s first coronavirus patient has found she had traces of the virus in her eyes for several weeks, even after it had become undetectable in nasal swabs. Read more
Profession to look ‘stronger than ever’ in new optometry documentary
The global eyecare community is poised for the virtual screening premiere of Open Your Eyes, a new documentary highlighting the increasing role of optometrists as frontline detectors of systemic diseases. Read more
Unlocking the secrets of the eye’s proteins
A new understanding of how proteins in the eye are prevented from clumping together has opened up new possibilities for the prevention and treatment of cataracts. Read more
Study dispels myths surrounding coronavirus and contact lens wear
An Australian professor has co-authored a new study addressing misinformation related to COVID-19 and contact lens wear, stating there is no evidence to suggest an increased risk compared with spectacle wear. Read more
Novartis provides safety update for Beovu
A safety review into Novartis’ new anti-VEGF drug Beovu has revealed that reported adverse events are consistent with the approved prescribing information after a group of US retinal specialists linked it to a series of vasculitis cases. Read more
Potential COVID-19 drug poses retinal toxicity risk
The Australian Therapeutic Goods Administration (TGA) has warned that an autoimmune and malaria drug being investigated as a potential treatment for COVID-19 can cause permanent retinal damage. Read more
Opthea progresses DME trials despite COVID-19 disruption
Results are imminent in biopharmaceutical company Opthea’s latest clinical trial evaluating the safety and efficacy of its lead drug candidate with Eylea in diabetic macular edema (DME) patients. Read more
Study examines ocular transmission of COVID-19
Researchers investigating links between COVID-19 and the eye have found there is a low risk of transmission via tears, after other studies established a link between the virus and conjunctivitis. Read more